Caixin

Business Brief (March 13): China Rejects U.S. Trade Probes Over ‘Excess Capacity’

Published: Mar. 13, 2026  2:50 p.m.  GMT+8
00:00
00:00/00:00
Listen to this article 1x

HOT TOPICS

China rejects U.S. trade probes over ‘excess capacity’

China firmly opposes any form of unilateral tariff measures and considers the narrative of overcapacity a false proposition used as a pretext for political manipulation, the Ministry of Commerce said. The remarks came in response to U.S. President Donald Trump’s announcement of two new trade investigations into the “excess industrial capacity” of 16 major trading partners, including China. The ministry reiterated its consistent and clear stance on handling bilateral economic and trade issues.

loadingImg
Register to read this article for free.
Register

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Disclaimer
This is an AI-generated English rendering of original reporting or commentary published by Caixin Media. In the event of any discrepancies, the Chinese version shall prevail.
Share this article
Open WeChat and scan the QR code
DIGEST HUB
Digest Hub Back
Explore the story in 30 seconds
  • China rejects U.S. trade investigations over “excess capacity,” criticizing unilateral tariff measures.
  • Cambricon Technologies reported a 2025 net profit of 2.1 billion yuan, with revenue up 453.2% year-on-year.
  • Iran’s new Supreme Leader warned of continued potential closure of the Strait of Hormuz amid escalating regional tensions.
AI generated, for reference only
Who’s Who
Cambricon Technologies Corp. Ltd.
Cambricon Technologies Corp. Ltd., a Chinese AI chipmaker, achieved a net profit of 2.1 billion yuan ($305 million) in 2025, a significant turnaround from previous losses. The company's revenue impressively surged by 453.2% year-on-year to 6.5 billion yuan, and it plans to distribute 632 million yuan in cash dividends.
Jacobio Pharmaceuticals Group Co. Ltd.
Jacobio Pharmaceuticals Group Co. Ltd. (德琪医药有限公司) anticipates achieving profitability in 2026. This forecast is based on an expected $100 million upfront payment from an upcoming licensing deal, which is projected to significantly improve its financial standing.
Pop Mart International Group Ltd.
Pop Mart International Group Ltd. experienced a rapid sell-out of its new Sanrio-themed Labubu blind boxes. These items were purchased within seconds of their release, indicating high demand for the company's products.
AI generated, for reference only
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’
00:00
00:00/00:00